SGIP1 alters internalization and modulates signaling of activated cannabinoid receptor 1 in a biased manner

@article{Hjkov2016SGIP1AI,
  title={SGIP1 alters internalization and modulates signaling of activated cannabinoid receptor 1 in a biased manner},
  author={Alena H{\'a}jkov{\'a} and {\vS}{\'a}rka Techlovsk{\'a} and Michaela Dvorakova and Jayne Nicole Chambers and Jiř{\'i} Kumpo{\vs}t and Pavla Hub{\'a}lkov{\'a} and Laurent Prézeau and Jaroslav Blaho{\vs}},
  journal={Neuropharmacology},
  year={2016},
  volume={107},
  pages={201-214}
}
View on Elsevier
doi.org
23 Citations
Highly Influential Citations
1
Background Citations
12
Methods Citations
3
Results Citations
2

Figures from this paper

23 Citations

SGIP1 modulates kinetics and interactions of the cannabinoid receptor 1 and G protein‐coupled receptor kinase 3 signalosome

The data suggest that the CB1R signalosome complex is dynamically controlled by sequential phosphorylation of the receptor C‐tail and is also modified by SGIP1.

Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R)

What is currently known about the trafficking pathways and protein interactions that underpin the surface expression and axonal polarity of CB1R are set out, and key questions that still need to be addressed are highlighted.

Structural Insights into CB1 Receptor Biased Signaling

In-depth studies using mutations, biological assays, and spectroscopic techniques, as well as computational modelling, have begun to reveal a set of concerted structural features in Class A GPCRs which relate to signaling pathways and the mechanisms of ligand-induced activation, deactivation, or activity modulation.

The C-terminal Helix 9 motif regulates cannabinoid receptor type 1 trafficking and surface expression

It is shown that the secretory pathway delivery of CB1R is axonally biased and that surface expressed CB1 R is more stable in axons than in dendrites, and that the C-terminal H9 domain plays key roles in this process.

Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB1R) Antagonist

CB1R promotes muscle insulin resistance via βArr2 signaling, selectively mitigated by a biased CB1R antagonist at reduced risk of central nervous system (CNS) side effects.

SGIP1 is involved in regulation of emotionality, mood, and nociception and modulates in vivo signalling of cannabinoid CB1 receptors

SGIP1 interferes with the internalization of activated CB1 receptors in transfected heterologous cells and may modulate affect, anxiety, pain processing, and other physiological processes controlled by the endocannabinoid system (ECS).

Cannabinoid receptor CB1 and CB2 interacting proteins: Techniques, progress and perspectives.

The C-terminal helix 9 motif in rat cannabinoid receptor type 1 regulates axonal trafficking and surface expression

Time-resolved imaging is used to determine the trafficking of CB1R from biosynthesis to mature polarised localisation in cultured rat hippocampal neurons and indicates that the C-terminal H9 domain plays key roles in this process.

Cannabinoid receptor interacting protein suppresses agonist‐driven CB1 receptor internalization and regulates receptor replenishment in an agonist‐biased manner

A novel role for CRIP1a in agonist‐driven CB1R cell surface regulation is demonstrated, postulated to occur by two mechanisms: 1) attenuating internalization that is agonists‐mediated, but not that in the absence of exogenous agonists, and 2) biased agonist-dependent trafficking of de novo synthesized receptor to the cell surface.

Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43

Using a high-throughput proteomic analysis complemented with an array of in vitro and in vivo approaches in the mouse brain, it is reported that the C -terminal, intracellular domain of CB_1R interacts specifically with growth-associated protein of 43 kDa (GAP43).

58 References

Distinct Roles of β-Arrestin 1 and β-Arrestin 2 in ORG27569-induced Biased Signaling and Internalization of the Cannabinoid Receptor 1 (CB1)*

The involvement of β-arrestin in CB1-biased signaling by a CB1 allosteric modulator is demonstrated for the first time and the differential role of the two β-Arrestin isoforms inCB1 signaling and internalization is defined.

Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling

Constitutive Activation Drives Compartment-Selective Endocytosis and Axonal Targeting of Type 1 Cannabinoid Receptors

It is found that constitutive-activity driven somatodendritic endocytosis is required for the proper axonal targeting of CB1R, representing a novel, conformation-dependent targeting mechanism for axonal GPCRs.

Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation

In cultured autaptic hippocampal neurons, CRIP1a overexpression attenuated both depolarization-induced suppression of excitation and inhibition of excitatory synaptic activity induced by exogenous application of cannabinoid but not by adenosine A1 agonists, appearing to act as a broad negative regulator of CB1R function.

Altered surface trafficking of presynaptic cannabinoid type 1 receptor in and out synaptic terminals parallels receptor desensitization

The results suggest that decrease of mobility may be one of the core mechanisms underlying the desensitization of CB1R, the most abundant G protein-coupled receptor in the brain.

Distinct Domains of the CB1 Cannabinoid Receptor Mediate Desensitization and Internalization

It is established that CB1 desensitization can be regulated by a GRK and that different receptor domains are involved in GRK- and β-arrestin-dependent desensItization and CB1 internalization.

Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors.

This work found that in COS-7 cells, ERK activation by the alpha(2A) AR, like that mediated by both the beta(2) AR and the epidermal growth factor receptor (EGFR), is sensitive to mechanistically distinct inhibitors of clathrin-mediated endocytosis, and determines that it is the receptor tyrosine kinase or another downstream effector that must engage the endocytic machinery.

Protein Kinase C Disrupts Cannabinoid Actions by Phosphorylation of the CB1 Cannabinoid Receptor

It is found that phosphorylation of a G-protein-coupled receptor by protein kinase C (PKC) disrupts modulation of ion channels by the receptor, and PKC can disrupt ion channel modulation by receptor phosphorylated.

Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells.

Internalization and Recycling of the CB1 Cannabinoid Receptor

It is found that CB1 receptors are rapidly internalized following agonist binding and receptor activation, and this results show thatCB1 receptor trafficking is dynamically regulated by cannabimimetic drugs.
...